Lupin Valbenazine Capsules FDA approved

Lupin Receives Provisional FDA Approval for its Valbenazine Capsules

To market a generic version of Ingrezza® Capsules, 40 mg, 60 mg, and 80 mg of Neurocrine Biosciences, Inc., Lupin Limited (Lupin) today announced that its Abbreviated New Drug Application (ANDA), Valbenazine Capsules, 40 mg, 60 mg, and 80 mg, has received provisional approval from the United States Food and Drug Administration (U.S. FDA).

Read More
error

Enjoy this blog? Please spread the word :)

WhatsApp
LinkedIn
Share
Follow by Email
RSS
“pharmaceutical r&d unveiled : 33 must know interview questions and game changing insights ! ”. This gallery contains. Balochistan government jobs.